Insight Molecular Diagnostics Inc (OCX)

Currency in USD
2.01
0.00(0.00%)
Real-time Data·

OCX Earnings

Latest Release
Nov 12, 2019
EPS / Forecast
-- / -0.09
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2019--/-0.09--/------Free Sign Up
06/2019-0.1/-0.09--/---11.11%--Free Sign Up

All numbers in

Insight Molecular Diagnostics Inc Earnings Call Summary for Q2/2025

  • Q2 laboratory services revenue at $494,000, slightly below $500,000 target; gross margins nearly 68%
  • Launched second-generation GraftAssure IQ kits; preparing FDA submission for kidney transplant rejection test by end of 2025
  • Cash position at $26 million; quarterly burn rate of $6.3 million plus $350,000 in capital expenditures
  • Anticipates FDA approval between Q2-Q3 2026; plans commercial launch mid-2026 with $6 million average quarterly cash burn
  • Exploring expansion into heart, lung, and liver transplant indications to diversify market presence
Last Updated: 11/08/2025, 23:24
Read Full Transcript
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.